{"disease":{"id":"ulcerative-colitis-flare","name":"ulcerative colitis flare"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04926103","title":"Screening Donors, Fecal Microbiota Transplant Program in Ulcerative Colitis","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Hamilton Health Sciences Corporation","has_results":false},{"nct_id":"NCT05405465","title":"Effectiveness of Golimumab in Patients With Ulcerative Colitis: Results of a Real-life Study in Switzerland","phase":"","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT03394586","title":"Real-world Data Regarding Treatment of Ulcerative Colitis Patients With Golimumab","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT06652464","title":"Maresin-1 and Resolvin-D1 Levels and Disease Activity in Ulcerative Colitis","phase":"","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital","has_results":false},{"nct_id":"NCT05998213","title":"Transfer of Feces in Ulcerative Colitis 2","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT04276740","title":"MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":79,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT05680883","title":"Local and Systemic Immunoprofiling of Patients Diagnosed With Ulcerative Colitis","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT03798210","title":"Lactobacillus Reuteri ATCC PTA 4659 in Ulcerative Colitis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Uppsala University","has_results":false},{"nct_id":"NCT05466890","title":"Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":16,"lead_sponsor_name":"Palatin Technologies, Inc","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}